If your doctor has mentioned DRG stimulation or spinal cord stimulation (SCS) as options for your chronic pain, you are probably wondering: what is the difference, and which one is right for me? Both are minimally invasive, drug-free therapies that use gentle electrical pulses to interrupt pain signals. But they work differently and suit different conditions.

Quick Answer

Choose DRG Stimulation if: your pain is focused in one area such as the foot, knee, hip, or groin, or you have CRPS.

Choose SCS if: you have widespread back or leg pain, or persistent pain after spine surgery.

What Is DRG Stimulation?

DRG stimulation targets the dorsal root ganglion, a specific cluster of nerve cells along your spine that relays pain signals from a defined body region to your brain. By placing an electrode directly at this cluster, the therapy is extremely precise, making it ideal for localized pain in areas like the foot, knee, or groin that traditional SCS struggles to reach.

FDA-Approved for: CRPS types I and II in the lower limbs. Available in the U.S. since approximately 2016.

What Is Spinal Cord Stimulation (SCS)?

SCS is the more established therapy, used since the 1960s. It delivers electrical impulses along the spinal cord to block widespread pain signals. Because coverage is broader, it is ideal for generalized back pain, leg pain, and failed back surgery syndrome (FBSS). Newer technologies like high-frequency and closed-loop SCS have significantly improved outcomes and comfort.

FDA-Approved for: A wide range of chronic pain conditions including back pain, FBSS, CRPS, and neuropathic pain.

DRG vs. SCS: At a Glance

Feature DRG Stimulation Spinal Cord Stimulation
Best forFoot, knee, hip, groin, CRPSBack pain, leg pain, FBSS
PrecisionHigh, localized targetingBroad spinal coverage
Position sensitivityMinimalCan vary (improving with new tech)
Tingling sensationRarelyCommon with traditional SCS
Pain relief rate~74% at 12 months*~53 to 60% at 12 months*
Insurance coverageLess universalWidely covered

*Based on the ACCURATE trial and BOOST-DRG study (Neuromodulation, 2024). Individual outcomes vary.

3 Key Differences to Know

1. Precision vs. Coverage

DRG stimulation is highly targeted, hitting one specific pain location with strong accuracy. SCS is broader, covering larger areas of the body. If your pain is concentrated in one spot, DRG is often the better fit. If it is widespread, SCS is more practical.

2. Position Sensitivity

DRG stimulation provides consistent relief regardless of body position. Traditional SCS can fluctuate as you sit, stand, or lie down. Modern closed-loop SCS systems have largely addressed this issue, making both options more comparable in daily comfort.

3. Tingling Sensation

Older SCS often causes a tingling feeling (paresthesia) over the painful area. DRG stimulation is typically free of this sensation. High-frequency SCS at 10 kHz has also reduced paresthesia significantly in recent years.

Who Should Consider DRG Stimulation?

  • Pain localized to the foot, knee, hip, or groin
  • Diagnosed with CRPS types I or II
  • SCS has not provided adequate relief
  • Prefer to avoid the tingling sensation of traditional SCS

Who Should Consider SCS?

  • Widespread chronic back or leg pain
  • Failed back surgery syndrome (FBSS)
  • Want a treatment backed by decades of clinical evidence
  • Broader insurance coverage is a priority

Frequently Asked Questions

Is DRG stimulation better than SCS?

It depends on your condition. For CRPS and localized lower limb pain, DRG has shown higher success rates (74% vs. 53% in the ACCURATE trial). For widespread back pain, SCS is equally effective and more widely available.

Is it covered by insurance?

SCS has broad coverage across most insurers. DRG stimulation is covered by Medicare and many private plans for CRPS, but may require pre-authorization. Always verify with your insurer before scheduling.

What if the trial does not work?

Both treatments start with a 5 to 10 day trial period. If results are unsatisfactory, the leads are simply removed with no permanent commitment. A failed trial leaves all future options open.

Bottom Line

Localized pain? DRG stimulation's precision may be your best option. Widespread pain? SCS has decades of evidence and continues to advance rapidly.

Either way, a risk-free trial period lets you experience results before committing. Work with a board-certified pain management specialist experienced in both technologies to find the best fit for your condition and lifestyle.